Marisol Quintero
pharmacologistFemale0.0Global Dominance: 0.00%
Marisol Quintero is a pharmacologist and the CEO of Highlight Therapeutics, a company dedicated to developing new cancer treatments, including BO-112. With a background in leading innovation at the CNIO, she has played a crucial role in advancing clinical trials and securing funding for cancer research.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Marisol Quintero is the director general of Highlight Therapeutics, overseeing the development of experimental cancer drugs.
La odisea de tres mujeres y el BO-112, la molécula que engaña al cáncer | CienciaEl País·
Spain· 2025-08-03
Spain· 2025-08-03
